[go: up one dir, main page]

ES2137378T3 - Estructuras peptidicas poliramificadas para ser utilizadas contra el hiv. - Google Patents

Estructuras peptidicas poliramificadas para ser utilizadas contra el hiv.

Info

Publication number
ES2137378T3
ES2137378T3 ES94926312T ES94926312T ES2137378T3 ES 2137378 T3 ES2137378 T3 ES 2137378T3 ES 94926312 T ES94926312 T ES 94926312T ES 94926312 T ES94926312 T ES 94926312T ES 2137378 T3 ES2137378 T3 ES 2137378T3
Authority
ES
Spain
Prior art keywords
hiv
cell
membrane
gpgr
receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94926312T
Other languages
English (en)
Inventor
Jean Marc Sabatier
Abdelaziz Benjouad
Nouara Yahi
Emmanuel Fenouillet
Kamel Mabrouk
Jean-Claude Gluckman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Armel SA
Original Assignee
Armel SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939318901A external-priority patent/GB9318901D0/en
Application filed by Armel SA filed Critical Armel SA
Application granted granted Critical
Publication of ES2137378T3 publication Critical patent/ES2137378T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE PRESENTAN CONSTRUCCIONES DE PEPTIDOS DE RAMAS MULTIPLES FORMADAS A PARTIR DE PEPTIDOS DERIVADOS DEL BUCLE V3 DE LA PROTEINA GP120 DEL HIV-1, Y QUE INCLUYEN LA SECUENCIA DE CONSENSO GPGR PRECEDIDA POR ENTRE 0 Y 4 AMINOACIDOS Y SEGUIDA POR ENTRE 2 Y 4 AMINOACIDOS, NO INCLUYENDO PREFERIBLEMENTE I EN LOS AMINOACIDOS QUE PRECEDEN INMEDIATAMENTE LA GPGR Y MAS PREFERIBLEMENTE LA GPGRAF, LAS CONSTRUCCIONES MUESTRAN UNA AFINIDAD RECEPTORA INCREMENTADA Y EVITAN LA FUSION CELULA A CELULAS. TIENEN DIFERENTES EFECTOS VIROSTATICOS. A CAUSA DE QUE PRESENTAN LA MISMA SECUENCIA DE PEPTIDO VARIAS VECES, ESTOS MBPCS SON CAPACES DE NEUTRALIZAR "IN VITRO" LOS DIFERENTES PASOS DE LA FUSION DE LA MEMBRANA DE LA CUBIERTA/CELULA Y LA FUSION DE LA MEMBRANA DE LA CELULA INFECTADA/DE LA MEMBRANA DE LA CELULA NO INFECTADA DE DIFERENTES CEPAS DEL HIV-1 Y DEL HIV-2. NOTABLEMENTE, SON EFECTIVAS EN EL BLOQUEO TANTO DE LOS RECEPTORES CD4 EN LOS LINFOCITOS Y LOS MACROFAGOS COMO EN LOS RECEPTORES GALCER EN LAS CELULAS EPITELIALES DEL COLON. ESTO DA COMO RESULTADO UN USO POTENCIAL EN EL TRATAMIENTO DE LAS INFECCIONES POR HIV-1 Y HIV-2.
ES94926312T 1993-09-13 1994-09-13 Estructuras peptidicas poliramificadas para ser utilizadas contra el hiv. Expired - Lifetime ES2137378T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939318901A GB9318901D0 (en) 1993-09-13 1993-09-13 Multiple branch peptide construction
US08/260,086 US5622933A (en) 1993-09-13 1994-06-15 Multiple branch peptide constructions for use against HIV

Publications (1)

Publication Number Publication Date
ES2137378T3 true ES2137378T3 (es) 1999-12-16

Family

ID=26303508

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94926312T Expired - Lifetime ES2137378T3 (es) 1993-09-13 1994-09-13 Estructuras peptidicas poliramificadas para ser utilizadas contra el hiv.

Country Status (15)

Country Link
EP (1) EP0719281B1 (es)
CN (1) CN1130911A (es)
AP (1) AP502A (es)
AT (1) ATE183201T1 (es)
AU (1) AU7619694A (es)
BR (1) BR9407530A (es)
DE (1) DE69420042T2 (es)
DK (1) DK0719281T3 (es)
ES (1) ES2137378T3 (es)
GR (1) GR3031367T3 (es)
HU (1) HUT75092A (es)
IL (1) IL110929A0 (es)
OA (1) OA10271A (es)
PL (1) PL313520A1 (es)
WO (1) WO1995007929A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719049B1 (fr) * 1994-04-22 1996-06-14 Pasteur Institut Multireprésentation d'un analogue peptidique du substrat de la DPPIV, notamment de type KPR, afin d'inhiber l'entrée du HIV dans les cellules.
GB9627114D0 (en) * 1996-12-31 1997-02-19 Centre Nat Rech Scient Multiple branch peptide constructions
GB9727424D0 (en) * 1997-12-31 1998-02-25 Armel Sa Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus
CN1100564C (zh) * 2001-08-29 2003-02-05 周根发 用于治疗hiv感染的药物、其组合物及其用途
US20060229433A1 (en) * 2003-05-20 2006-10-12 Cellpep Sa Modified antiviral peptides with increased activity and cell membrane affinity
US7604804B2 (en) 2004-02-09 2009-10-20 University Of Maryland Biotechnology Institute Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric gp120
WO2009032605A2 (en) * 2007-08-27 2009-03-12 Massachusetts Institute Of Technology Bi-functional polymer-attached inhibitors of influenza virus
CN102532280A (zh) * 2010-12-08 2012-07-04 吉林大学 一种hiv免疫原及其制备
CN104415739A (zh) * 2013-08-28 2015-03-18 天津市阳权医疗器械有限公司 苯乙烯-二乙烯苯医用树脂的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
EP0536352B1 (en) * 1991-04-02 2003-12-17 Albert Einstein College Of Medicine Of Yeshiva University Therapeutic and preventive vaccines for hiv
WO1993003766A1 (en) * 1991-08-13 1993-03-04 Repligen Corporation Multiple antigen peptides for use as hiv vaccines

Also Published As

Publication number Publication date
HUT75092A (en) 1997-04-28
PL313520A1 (en) 1996-07-08
OA10271A (en) 1997-10-07
AU7619694A (en) 1995-04-03
GR3031367T3 (en) 2000-01-31
BR9407530A (pt) 1997-08-26
AP9400680A0 (en) 1994-10-31
EP0719281A1 (en) 1996-07-03
HU9600594D0 (en) 1996-05-28
ATE183201T1 (de) 1999-08-15
DK0719281T3 (da) 2000-03-20
IL110929A0 (en) 1994-11-28
AP502A (en) 1996-06-07
EP0719281B1 (en) 1999-08-11
WO1995007929A1 (en) 1995-03-23
CN1130911A (zh) 1996-09-11
DE69420042D1 (de) 1999-09-16
DE69420042T2 (de) 2000-04-13

Similar Documents

Publication Publication Date Title
LYERLY et al. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC
CA2164818A1 (en) Tandem synthetic hiv-1 peptides
ES2227527T3 (es) Un factor de crecimiento de queratinocitos (kgf) truncado que tiene actividad biologica aumentada.
ES2138086T3 (es) Constructo de peptido sintetico compuesto que provoca anticuerpos neutralizantes y linfocitos t citotoxicos contra hiv.
AR017780A1 (es) Conjugado del factor de liberacion de hormona de crecimiento-polietilenenglicol (hgrf-peg) y metodo para la preparacion en sitio-especifico del mismo.
ES2124922T3 (es) Peptidos derivados de un retrovirus del grupo hiv y su uso.
MX9307686A (es) Preparacion de liberacion sostenida.
ES2192620T3 (es) Polipeptido receptor de il-13.
EP0517792A1 (en) Terminally blocked antiviral peptides
ES2137378T3 (es) Estructuras peptidicas poliramificadas para ser utilizadas contra el hiv.
ES2052368T3 (es) Factores sanguineos producidos por recombinacion y el proceso para la expresion de dichos factores, asi como recombinacion del virus de vaccina usados en dicho proceso.
DE69426725D1 (de) Peptide, die neutralisierende antikörper gegen genetisch divergierende hiv-1 stämme, induzieren
AP9901615A0 (en) Multiple branch peptide constructions.
CA2306441A1 (fr) Peptides issus de gene env du virus de l'immunodeficience feline et leurs applications
DE60143668D1 (de) Peptidinhibitoren gegen den eintritt von hiv in zellen
EP0960886B1 (en) Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
DE60325955D1 (de) Mehrfach verzweigte peptidkonstruktion mit 2 bis 16 verzweigungen des peptids rqgys oder 8 bis 16 verzweigungen des peptids rqgy aus dem hiv gp41 glycoprotein
CA2171531A1 (en) Multiple branch peptide constructions for use against hiv
US6610304B1 (en) Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus
ES2095899T3 (es) Peptidos de la proteina gag de vih, su preparacion y uso.
WO2004104031A2 (en) Modified antiviral peptides with increased activity and cell membrane affinity
ES2165042T3 (es) Vacuna que contiene el virus de la artritis-encefalitis de cabra y utilizacion para inmunoproteccion contra la infeccion por hiv-1.
TH22767A (th) เพทไทด์ชนิดหลายแขนงที่สร้างขึ้นสำหรับใช้ต่อ hiv
KR890011607A (ko) 소염제 및 면역소절제로서 사이클로필린의 용도
DE69130571D1 (de) Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 719281

Country of ref document: ES